Therefore, this study suggested that the FOXD3 gene might inhibit the development of EMT and regulate the proliferation of colon cancer bone metastasis cells through the EGFR-RAS-Raf-MEK-ERK signaling pathway, thereby exhibiting a potential for novel future therapies. Here, FOXD3 is linked to malignant colon neoplasm.